Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Vaccine

Vinay Prasad vs the FDA: How One Doctor's Policies Collided with Politics and Cost Him His Job

Vinay Prasad resigns from the FDA after backlash over vaccine restrictions and gene therapy decisions. Political pressure cited in sudden departure.

International Business Times UK

Cautious Optimism As Merck Leans On Oncology Amid Gardasil Vaccine Concerns

Pharmaceutical giants are navigating a complex landscape of fluctuating demand and regulatory hurdles, impacting their financial performance and strategic outlook. Merck Co. Inc. (NYSE:MRK) is the latest to face these challenges, as its recent earnings report reveals a mixed bag of successes and setbacks.

Benzinga

'Universal' cancer vaccine heading to human trials could be useful for 'all forms of cancer'

A new mRNA-based vaccine triggers a response from the innate immune system to help arm the body against cancer, a mouse study finds. It's now in early human trials.

LiveScience

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA’s top vaccine official leaves post after less than four months

Trump administration gives no details about reason for departure of Vinay Prasad, but he had critics and had taken unusual actions

The Guardian - US

GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth

British pharmaceutical giant GSK Plc (NYSE:GSK) shares rose on Wednesday after reporting second-quarter results that surpassed analyst expectations and led the company to raise its full-year 2025 guidance.

Benzinga

US medical groups fill gap with own vaccine guides amid ‘information crisis’

As official health guidance changes, scientific groups are stepping in with evidence-based recommendations

The Guardian - US

1 Analyst Thinks This Former Pandemic Winner Could Surge 500% This Year

This risky biotech company faces significant challenges ahead. But it has already proven its worth and may be able to do so again.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Robert Kennedy Jr Blasts Vaccine Injury Compensation Program: 'Devolved Into A Morass Of Inefficiency, Favoritism, And Outright Corruption'

Health and Human Services Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the National Vaccine Injury Compensation Program, describing the system as fundamentally broken and failing its intended purpose.

Benzinga

RFK Jr. sets out to ‘discover’ what causes autism by September, and vaccine lawyers could get very rich from the results

Discover by autumn, sue by winter.

We Got This Covered

RFK Jr. looks to boot panel that decides which HIV and cancer screenings will be free: report

Decisions from the U.S. Preventative Services Task Force impact millions of people’s access to preventative care for cancer, infectious diseases and mental health

The Independent UK

Scientists gave mice flu vaccines by flossing their tiny teeth — and it worked

In a proof-of-concept study, scientists have shown that flossing your teeth could be a way to deliver vaccinations that protect you against viruses.

LiveScience

Parents seeking religious exemptions to school vaccines win reprieve in a West Virginia county

A West Virginia judge has allowed children from three families to attend school without required vaccinations

The Independent UK

Vaccine-Skeptic RFK Jr. Finalizes Ban On Mercury-Based Thimerosal In US Flu Vaccines

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. approved a major policy change on Tuesday that will remove the mercury-based preservative thimerosal from all flu vaccines distributed in the U.S.

Benzinga

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates

Novavax, Inc. (NASDAQ:NVAX) on Thursday revealed preclinical data from the H5N1 avian pandemic influenza vaccine candidate.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

What's Going On With Moderna Stock Wednesday?

Moderna Inc.’s (NASDAQ:MRNA) stock has surged approximately 37% in the last month but has dipped around 15% year to date.

The Guardian - US

RFK Jr to remove preservative thimerosal from all US vaccines

Anti-vaccine campaigns have targeted thimerosal for decades despite no evidence of ingredient causing harm

Roll Call

Kennedy adopts panel's advice to remove flu shot ingredient - Roll Call

Vaccine makers removed thimerosal from roughly 95 percent of flu vaccinations in 1999 following unfounded claims about mercury.

The Guardian - UK

Look at the rise of measles in England and ask yourself: have we learned a single thing from Covid?

People grow complacent about vaccines precisely because they are so effective. What happened to collective responsibility, asks Guardian columnist Frances Ryan

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy

Sanofi SA (NASDAQ:SNY) on Tuesday agreed to acquire Vicebio Ltd, a privately held biotechnology company headquartered in London, U.K.

The Guardian - UK

Make Lime bikes free for teenagers

Brief letters: Incentives for good behaviour | Writing to royals | Sterilising light switches | ‘Vaccine hesitancy’ | Always against genocide

The Conversation

How falling vaccination rates are fuelling the antibiotic resistance crisis

Antibiotic resistance is one of the biggest health threats we face today. It’s often blamed on the overuse of antibiotics, and for a good reason. But there’s another major factor quietly driving this crisis that doesn’t get as much attention: low vaccination rates.

Kids Ain't Cheap

Think Again: 5 Vaccinations Parents Are Skipping Putting Kids At Risk

Image source: 123rf.com

Euronews

Billion euro deal: Sanofi buys UK biotech company to expand respiratory vaccine portfolio

French pharmaceutical company Sanofi said it is acquiring London-based Vicebio to expand its range of respiratory virus vaccines and add a non-mRNA vaccine to its pipeline.

The Conversation

COVID, flu, RSV: how these common viruses are tracking this winter – and how to protect yourself

Winter is here, and with it come higher rates of respiratory illnesses. If you’ve been struck down recently with a sore throat, runny nose and a cough, or perhaps even a fever, you’re not alone.

International Business Times UK

In-N-Out Billionaire on Why She's Ditching California: 'Raising a Family and Doing Business Isn't Easy Here'

In-N-Out previously refused to comply with California's vaccine card mandates during the pandemic, which led to temporary closures.

1 … 46 47 48 49

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Health and Human Services

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.